187 related articles for article (PubMed ID: 36117665)
21. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
[TBL] [Abstract][Full Text] [Related]
22. Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments.
He B; Chen Z; Nie Y; Luo M; Xu S; Yan J; Chen Z
J Immunol Res; 2022; 2022():6588144. PubMed ID: 35733920
[TBL] [Abstract][Full Text] [Related]
23. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW
Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255
[TBL] [Abstract][Full Text] [Related]
24. Multiple Mechanisms of Shenqi Pill in Treating Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking.
Tong X; Xu S; Zhai D
Evid Based Complement Alternat Med; 2022; 2022():2384140. PubMed ID: 35795275
[TBL] [Abstract][Full Text] [Related]
25. Network Pharmacology-Based Investigation of the Therapeutic Mechanisms of Action of Danning Tablets in Nonalcoholic Fatty Liver Disease.
Lin T; Li L; Liang C; Peng L
Evid Based Complement Alternat Med; 2021; 2021():3495360. PubMed ID: 33995543
[TBL] [Abstract][Full Text] [Related]
26. Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics.
Cao YJ; Li HZ; Zhao J; Sun YM; Jin XW; Lv SQ; Luo JY; Fang XX; Wen WB; Liao JB
Evid Based Complement Alternat Med; 2022; 2022():2264394. PubMed ID: 35845577
[TBL] [Abstract][Full Text] [Related]
27. A Network Pharmacology Study on the Active Components and Targets of the Radix Ginseng and Radix Bupleuri Herb Pair for Treating Nonalcoholic Fatty Liver Disease.
Zhang Q; Zhang L; Liu K; Shang H; Ruan J; Yu Z; Meng S; Liang F; Wang T; Zhang H; Peng W; Wang Y; Chen J; Xiao T; Wang B
Evid Based Complement Alternat Med; 2022; 2022():1638740. PubMed ID: 35178098
[TBL] [Abstract][Full Text] [Related]
28. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
[TBL] [Abstract][Full Text] [Related]
29. Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPAR
Huang P; Yang L; Liu Y; Jiang Y; Li Y; Chen Z; Song H; Zheng P
Evid Based Complement Alternat Med; 2022; 2022():1124901. PubMed ID: 35035496
[TBL] [Abstract][Full Text] [Related]
30. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.
Gao SS; Sun JJ; Wang X; Hu YY; Feng Q; Gou XJ
Biomed Res Int; 2020; 2020():1704960. PubMed ID: 33204683
[TBL] [Abstract][Full Text] [Related]
31. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
[TBL] [Abstract][Full Text] [Related]
32. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
[TBL] [Abstract][Full Text] [Related]
33. Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking.
Luo Z; Xia LY; Tang YQ; Huang L; Liu D; Huai WY; Zhang CJ; Wang YQ; Xie YM; Yin QZ; Chen YH; Zhang TE
Evid Based Complement Alternat Med; 2022; 2022():1670014. PubMed ID: 35096103
[TBL] [Abstract][Full Text] [Related]
34. Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation.
Shi H; Qiao F; Huang K; Lu W; Zhang X; Ke Z; Wu Y; Cao L; Chen Y
J Ethnopharmacol; 2022 Oct; 296():115477. PubMed ID: 35764198
[TBL] [Abstract][Full Text] [Related]
35. Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation.
Ma C; Wang X; Zhang J; Zhao Y; Hua Y; Zhang C; Zheng G; Yang G; Guan J; Li H; Li M; Kang L; Xiang J; Fan G; Yang S
Front Pharmacol; 2022; 13():893336. PubMed ID: 35774609
[TBL] [Abstract][Full Text] [Related]
36. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
37. [Mechanism of Triclosan in the Treatment of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology].
Zuo C; Sun DL; Zhao TH; Wang JJ; Zhang ZZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Apr; 44(2):253-261. PubMed ID: 35538760
[TBL] [Abstract][Full Text] [Related]
38. Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease.
Zhang M; Yuan Y; Zhou W; Qin Y; Xu K; Men J; Lin M
Comput Biol Chem; 2020 Jun; 86():107248. PubMed ID: 32208163
[TBL] [Abstract][Full Text] [Related]
39. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
40. Integration of Lipidomics and Transcriptomics Reveals the Efficacy and Mechanism of Qige Decoction on NAFLD.
Fan S; Zhou Z; Ye J; Li Y; Huang K; Ke X
Evid Based Complement Alternat Med; 2022; 2022():9739032. PubMed ID: 36452137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
